COVID-19

Achievement of india in COVID-19. Drug major Glenmark Pharmaceuticals has become the first Indian company to commercially launch an antiviral drug for the treatment of mild to moderate COVID-19 patients after it received the Indian drug regulator Drug Controller General of India (DCGI) approval. The drug Favipiravir, under the brand name FabiFlu, will be available as a 200 mg tablet at a maximum retail price (MRP) of Rs 3,500 for a strip of 34 tablets, Glenmark Pharmaceuticals said. Effectively, one tablet of FabiFlu would cost Rupees 103.  all you need to know about glenmark's COVID-19 treatment medicine: Glenmark is the first pharma firm to get approval for an oral drug to treat COVID-19 patients in India. Priced at Rs 3,500 for 34 tablets, the dosage is 200 mg X 9 tablets on day one and 200 mg X 4 tablets a day for 14 days. Global trials show the efficacy of over 80-88%; Japan, Bangladesh and UAE already use the drug for COVID-19 treatment. The drug will be available both throug...

CORONA VIRUS.   INTRODUCTION: WHO has declared the coronavirus disease 2019 a pandemic. A global coordinated effort is needed to stop the further speed of virus. A pandemic is defined as "occurring over a wide geographic area and affecting an exceptionally high proportion of the population." HISTORY: Corona virus were first discovered in the 1930s when an acute respiratory infection of domesticated chickens was shown to be caused by infectious bronchitis virus (IBV). The infection of new born chickens was characterized by gasping and listlessness. The chick’s mortality rate was 40-90%. Fred beaudette and Charles Hudson six years later successfully isolated and cultivated the infectious bronchitis virus which caused disease. In 1940s two more animal coronavirus, mouse hepatitis virus (MHV) and transmissible gastroenteritis virus (TGEV) were isolated. Human coronavirus was discovered in the 1960s.they were isolated using two different methods in the UK and the U...